 | • レポートコード：MRC2206A033 • 出版社/出版日：Transparency Market Research / 2022年4月 • レポート形態：英文、PDF、340ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査レポートでは、世界のウシ胎児血清（FBS）市場を調査対象とし、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、用途別（創薬、細胞培地培養、体外受精、ヒト＆動物用ワクチン製造、診断）分析、エンドユーザー別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況など、以下の内容をまとめております。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界のウシ胎児血清（FBS）市場規模：用途別（創薬、細胞培地培養、体外受精、ヒト＆動物用ワクチン製造、診断） ・世界のウシ胎児血清（FBS）市場規模：エンドユーザー別 ・世界のウシ胎児血清（FBS）市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Fetal Bovine Serum Market – Scope of Report
TMR’s report on the global fetal bovine serum market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global fetal bovine serum market for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global fetal bovine serum market from 2021 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the fetal bovine serum market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global fetal bovine serum market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global fetal bovine serum market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global fetal bovine serum market.
The report delves into the competitive landscape of the global fetal bovine serum market. Key players operating in the global fetal bovine serum market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global fetal bovine serum market profiled in this report.
Key Questions Answered in Fetal Bovine Serum Market Report
What will be the sales/revenue generated by fetal bovine serum across all regions during the forecast period?
What are the opportunities in the global fetal bovine serum market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which application is expected to generate the highest revenue globally in 2031? Which segment is projected to expand at the highest CAGR during the forecast period?
What is the market position of different companies operating in the global market?
Fetal Bovine Serum Market – Research Objectives and Research Approach
The comprehensive report on the global fetal bovine serum market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global fetal bovine serum market in terms of application, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global fetal bovine serum market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Fetal Bovine Serum Market
4. Market Overview
4.1. Introduction
4.1.1. Application Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Fetal Bovine Serum Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.2. Pipeline Analysis
5.3. Regulatory scenario, by Region/Globally
5.4. Covid-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Fetal Bovine Serum Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Application, 2017-2031
6.3.1. Drug Discovery
6.3.2. Cell Media Culture
6.3.3. In Vitro Fertilization
6.3.4. Human & Animal Vaccine Production
6.3.5. Diagnostics
6.3.6. Others
6.4. Market Attractiveness Analysis, by Application
7. Global Fetal Bovine Serum Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017-2031
7.3.1. Research & Academic Institutes
7.3.2. Industry (pharma, biotech, etc.)
7.3.3. Healthcare Facilities
7.4. Market Attractiveness Analysis, by End-user
8. Global Fetal Bovine Serum Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Fetal Bovine Serum Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Application, 2017-2031
9.2.1. Drug Discovery
9.2.2. Cell Media Culture
9.2.3. In Vitro Fertilization
9.2.4. Human & Animal Vaccine Production
9.2.5. Diagnostics
9.2.6. Others
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Research & Academic Institutes
9.3.2. Industry (pharma, biotech, etc.)
9.3.3. Healthcare Facilities
9.4. Market Value Forecast, by Country, 2017-2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Application
9.5.2. By End-user
9.5.3. By Country
10. Europe Fetal Bovine Serum Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Application, 2017-2031
10.2.1. Drug Discovery
10.2.2. Cell Media Culture
10.2.3. In Vitro Fertilization
10.2.4. Human & Animal Vaccine Production
10.2.5. Diagnostics
10.2.6. Others
10.3. Market Value Forecast, by End-user, 2017-2031
10.3.1. Research & Academic Institutes
10.3.2. Industry (pharma, biotech, etc.)
10.3.3. Healthcare Facilities
10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Application
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Fetal Bovine Serum Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Application, 2017-2031
11.2.1. Drug Discovery
11.2.2. Cell Media Culture
11.2.3. In Vitro Fertilization
11.2.4. Human & Animal Vaccine Production
11.2.5. Diagnostics
11.2.6. Others
11.3. Market Value Forecast, by End-user, 2017-2031
11.3.1. Research & Academic Institutes
11.3.2. Industry (pharma, biotech, etc.)
11.3.3. Healthcare Facilities
11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Application
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Fetal Bovine Serum Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Application, 2017-2031
12.2.1. Drug Discovery
12.2.2. Cell Media Culture
12.2.3. In Vitro Fertilization
12.2.4. Human & Animal Vaccine Production
12.2.5. Diagnostics
12.2.6. Others
12.3. Market Value Forecast, by End-user, 2017-2031
12.3.1. Research & Academic Institutes
12.3.2. Industry (pharma, biotech, etc.)
12.3.3. Healthcare Facilities
12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Application
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Fetal Bovine Serum Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Application, 2017-2031
13.2.1. Drug Discovery
13.2.2. Cell Media Culture
13.2.3. In Vitro Fertilization
13.2.4. Human & Animal Vaccine Production
13.2.5. Diagnostics
13.2.6. Others
13.3. Market Value Forecast, by End-user, 2017-2031
13.3.1. Research & Academic Institutes
13.3.2. Industry (pharma, biotech, etc.)
13.3.3. Healthcare Facilities
13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Application
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix
14.2. Market Share Analysis, by Company, 2020
14.3. Company Profiles
14.3.1. ANZCO Foods (Bovogen Biologicals Pvt. Ltd.)
14.3.1.1. Company Overview
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. Business Strategies
14.3.1.5. Recent Developments
14.3.2. ATCC
14.3.2.1. Company Overview
14.3.2.2. Financial Overview
14.3.2.3. Product Portfolio
14.3.2.4. Business Strategies
14.3.2.5. Recent Developments
14.3.3. Bio-techne (Atlanta Biologicals, Inc.)
14.3.3.1. Company Overview
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. Business Strategies
14.3.3.5. Recent Developments
14.3.4. Captivate Bio
14.3.4.1. Company Overview
14.3.4.2. Financial Overview
14.3.4.3. Product Portfolio
14.3.4.4. Business Strategies
14.3.4.5. Recent Developments
14.3.5. Danaher (Cytiva)
14.3.5.1. Company Overview
14.3.5.2. Financial Overview
14.3.5.3. Product Portfolio
14.3.5.4. Business Strategies
14.3.5.5. Recent Developments
14.3.6. HiMedia Laboratories
14.3.6.1. Company Overview
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. Business Strategies
14.3.6.5. Recent Developments
14.3.7. Merck KGaA
14.3.7.1. Company Overview
14.3.7.2. Financial Overview
14.3.7.3. Product Portfolio
14.3.7.4. Business Strategies
14.3.7.5. Recent Developments
14.3.8. Pan Biotech GmbH
14.3.8.1. Company Overview
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. Business Strategies
14.3.8.5. Recent Developments
14.3.9. Rocky Mountain Biologicals
14.3.9.1. Company Overview
14.3.9.2. Financial Overview
14.3.9.3. Product Portfolio
14.3.9.4. Business Strategies
14.3.9.5. Recent Developments
14.3.10. TCS Biosciences Ltd.
14.3.10.1. Company Overview
14.3.10.2. Financial Overview
14.3.10.3. Product Portfolio
14.3.10.4. Business Strategies
14.3.10.5. Recent Developments
14.3.11. Thermo Fisher Scientific Inc.
14.3.11.1. Company Overview
14.3.11.2. Financial Overview
14.3.11.3. Product Portfolio
14.3.11.4. Business Strategies
14.3.11.5. Recent Developments
14.3.12. Zen-Bio, Inc.
14.3.12.1. Company Overview
14.3.12.2. Financial Overview
14.3.12.3. Product Portfolio
14.3.12.4. Business Strategies
14.3.12.5. Recent Developments
Table 01: Global Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 02: Global Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 03: Global Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 04: North America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 05: North America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 06: North America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 07: Europe Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 08: Europe Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 09: Europe Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 10: Asia Pacific Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 11: Asia Pacific Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 12: Asia Pacific Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Latin America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Latin America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 15: Latin America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Middle East & Africa Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Middle East & Africa Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 18: Middle East & Africa Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017–2031